Personalized Prostate Cancer Treatment: The Role of the Prolaris® Test March 10, 2023 Prostate cancer is a common cancer affecting men, and historically the most common approach to treatment would be either surgery or radiation therapy. However,... Continue Reading
American Cancer Society® Reports Increase in Late-Stage Prostate Cancer February 3, 2023 Amid the great news reported recently by the American Cancer Society — that overall deaths from cancer have dropped by a third since 1991, saving nearly 4 mi... Continue Reading
How is the Prostate Gleason Score Graded? Your Biopsy and Gleason Score Part 2 February 1, 2023 Geoff McLennan, Prostate Cancer Survivor and Advocate In part one of this blog series, I explained the different types of prostate biopsies available ... Continue Reading
Types of Prostate Biopsies: Your biopsy and Gleason score Part 1 January 23, 2023 Geoff McLennan, Prostate Cancer Survivor and Advocate A urologist will usually, but not always, suggest a biopsy of your prostate when there is reason ... Continue Reading
Prostate cancer can be hereditary, get peace of mind with Myriad Genetic Testing January 13, 2023 https://myriad-1.wistia.com/medias/yff9ux0rmk When Tim Petracca was diagnosed with prostate cancer at age 63, he began to think about his extensive fa... Continue Reading
Patient PSA Test Primer: Best times to test and how to prepare January 6, 2023 Geoff McLennan, Prostate Cancer Survivor and Advocate As men enter, or race, into middle-age, and their doctors add another level of care, the first of ma... Continue Reading
Prolaris® provides clarity for prostate cancer treatment decisions. A patient story. December 12, 2022 https://myriad-1.wistia.com/medias/70m1vw0uka Elevated PSA levels warning Tim Petracca was a healthy 63-year-old when he attended a regularly sched... Continue Reading
Patient Prostate Cancer Journey Part 3: Shared Decision-Making Benefits to Prostate Cancer Treatment December 1, 2022 A transparent, confident relationship with your urologist is important not only for your current health, but for your future health outcomes. The good new... Continue Reading
Patient Prostate Cancer Journey Part 2: Getting to Active Surveillance November 17, 2022 In my prior post, I described my surprising journey to an initial prostate diagnosis of hgpin, short for high-grade prostatic intraepithelial neoplasia. H... Continue Reading
Patient Prostate Cancer Journey Part 1: A Urology Exam Reveals Unexpected Results November 1, 2022 The day began positively average and uneventful. Dressed and ready for work, I mentioned to my wife, "I'll be home a bit later than usual - I have an appo... Continue Reading
Can a genetic test improve prostate cancer treatment decisions? A patient story. October 25, 2022 https://myriad-1.wistia.com/medias/w9go8af7h5 How can a prognostic test inform care plans for a patient with prostate cancer? Richard Tyus and his uro... Continue Reading
Consistent data matters. Prolaris® is the best answer for your prostate cancer patients. Submit the form below to learn why. August 26, 2022 Treating prostate cancer can be hard, Prolaris makes it easy Knowing if your prostate cancer patients are safe for active surveillance or if they would bene... Continue Reading
Myriad Genetics is committed to being your partner of choice August 5, 2022 Against the backdrop of recent shifts in the genetic testing industry, we would like to take a minute to reiterate Myriad Genetics’ determination to bring cl... Continue Reading
Understanding Prolaris test results June 17, 2022 After a prostate cancer diagnosis, choosing an appropriate treatment path can be incredibly stressful for you and your loved ones. Further complicating the pro... Continue Reading
What is the Prolaris test? June 10, 2022 The Prolaris test is a genetic test for untreated men with prostate cancer that can determine how quickly cancer is growing. Prolaris helps provide clarity abo... Continue Reading